Gareth Veal, Professor of Cancer Pharmacology at the Newcastle University Cancer Centre, leads a team helping doctors to personalise treatments through an innovative process called ‘therapeutic drug monitoring’. Here, he tells us more about his work.
New and innovative cancer treatments go through many steps to make their way from ‘bench to bedside’. Professor Pamela Kearns, Dr Sarah Al-Jilaihawi and Dr Jessica Douglas-Pugh from the University of Birmingham’s Cancer Research UK Clinical Trials Unit (CRCTU) explain more about this process.
Prof Robert Wynn, Consultant Paediatric Haematologist and Director of Bone Marrow Transplant at Royal Manchester Children’s Hospital, leads the GRANS clinical trial. He tells us how this innovative treatment is showing promising results for children with hard-to-treat leukaemia.
The Little Princess Trust (LPT) has announced 10 new research projects that will improve outcomes for children with cancer, awarded in partnership with Children’s Cancer and Leukaemia Group (CCLG).
In the UK and Ireland, over 100 childhood cancer researchers have been funded through CCLG. But what are they working on? Let's take a trip to the University of Oxford to find out...
The idea that everyone should be treated equally is great in principle – but is it enough? We look at the difference between equity and equality to see how it can affect young patients.
An important resource designed to support nurses who work in the field of long-term follow-up and late effects for children and young people after cancer has been updated and expanded.
Childhood cancer research has increased survival rates from just three in 10 children in the 1960s to over eight in ten children today thanks to dedicated researchers. So, what's next?
A team of fitness enthusiasts are preparing to take on an endurance-testing challenge to raise funds for a Children’s Cancer and Leukaemia Group (CCLG) Special Named Fund.
